Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis
PLOS One · 2026
DOI: 10.1371/journal.pone.0342085 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS One, 2026. Verfasst von Luciana Carla Martins de Aquino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Liga Contra o Câncer, Natal, Rio Grande do Norte, Brazil. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Breast cancer is the most common malignant tumor among women worldwide, with an estimated 2.3 million new cases and nearly 670,000 deaths reported in 2022. The absence of hormone receptors and HER2 in triple-negative breast cancer (TNBC) reduces therapeutic options, contributing to a poorer prognosis. Tumor-infiltrating lymphocytes (TILs) are cells present in the tumor microenvironment, associated with a better prognosis and potentially playing a role in patient stratification and therapeutic management in the future. This protocol aims to assess the prognostic value of TILs in the survival of patients with TNBC, as well as their relationship with disease recurrence.
Methods
Comprehensive search will be conducted in the following databases: PubMed, Embase, Lilacs, Web of Science, Scopus, SciELO, ScienceDirect, and the Cochrane Library. The search will include cohort, case-control, and clinical trials studies that approach the prognostic value of TILs in TNBC and their role in optimizing treatment strategies, and no language restrictions. Two independent reviewers will select articles based on predefined inclusion and exclusion criteria, extract data, and assess the risk of bias using the QUIPS tool. Data synthesis will be conducted using the “meta” package in R software, version 4.3.1.
Conclusions
This systematic review will synthesize current evidence on the prognostic significance of TILs in triple-negative breast cancer and their association with patient survival and disease recurrence. The findings may contribute to a better understanding of TILs as potential biomarkers for prognosis and guide future therapeutic strategies in TNBC management. Review registration: CRD42024568600 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oncology Department, Liga Contra o Câncer, Natal, Rio Grande do Norte, Brazil.
- Department of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
- Radiotherapy Department, Liga Contra o Câncer, Natal, Rio Grande do Norte, Brazil.
- Institute of Education, Research and Innovation, Liga Contra o Câncer, Natal, Rio Grande do Norte, Brazil.
- Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.
- Department of Obstetrics and Gynecology, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.
ORCID-Profile: Elisandra Inara Silva Andrade, Ana Katherine Gonçalves
Zitieren
APA
Aquino, L. C. M., Andrade, E. I. S., Nunes, L. M. F., Santos, E. M., Sarmento, A. C. A., Medeiros, K. S., & Gonçalves, A. K. (2026). Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis. PLOS One. https://doi.org/10.1371/journal.pone.0342085
Vancouver
Aquino LCM, Andrade EIS, Nunes LMF, Santos EM, Sarmento ACA, Medeiros KS, et al. Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis. PLOS One. 2026. doi:10.1371/journal.pone.0342085
BibTeX
@article{Aquino2026,
author = {Aquino, Luciana Carla Martins de and Andrade, Elisandra Inara Silva and Nunes, Luana Maria Ferreira and Santos, Edilmar de Moura and Sarmento, Ayane Cristine Alves and Medeiros, Kleyton Santos de and Gonçalves, Ana Katherine},
title = {Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0342085}
}
EUVIMED